OABI Q2 2024 Earnings — OmniAb, Inc. Revenue & Financial Results | Market Cap Arena

OABIOmniAb, Inc.

$231M

Q2 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$8M+9.6% YoY

Gross Profit

$8M100.0% margin

Operating Income

-$16M-214.1% margin

Net Income

-$14M-179.0% margin

EPS (Diluted)

$-0.13

QoQ Revenue Growth

+100.3%

Cash Flow

Operating Cash Flow

-$12M

Free Cash Flow

-$13M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$337M

Total Liabilities

$43M

Stockholders' Equity

$294M

Cash & Equivalents

$21M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$8M	$7M	+9.6%
Gross Profit	$8M	$2M	+265.0%
Operating Income	-$16M	-$19M	+15.5%
Net Income	-$14M	-$15M	+7.4%

Revenue Segments

Service

$4M93%

Royalty

$318,0007%